63896-87-7 Usage
Description
2,3-Dichloroacetoacetanilide, with the molecular formula C10H9Cl2NO3, is a white or off-white crystalline powder. It is a chemical compound that serves as an intermediate in the synthesis of pharmaceuticals and agricultural chemicals. Known for its enzyme-inhibiting properties, it plays a significant role in the development of herbicides and insecticides. Moreover, it has been investigated for its potential in treating cancer and other diseases. However, due to its toxicity and environmental impact, its use and handling are strictly regulated.
Uses
Used in Pharmaceutical Industry:
2,3-Dichloroacetoacetanilide is used as an intermediate in the synthesis of various pharmaceuticals for its ability to inhibit the activity of certain enzymes. This property makes it a valuable component in the development of drugs targeting specific enzyme pathways.
Used in Agricultural Chemical Industry:
In the agricultural sector, 2,3-Dichloroacetoacetanilide is used as an intermediate in the production of herbicides and insecticides. Its enzyme-inhibiting capabilities contribute to the effectiveness of these chemicals in controlling pests and unwanted plant growth.
Used in Cancer Research:
2,3-Dichloroacetoacetanilide is used as a potential therapeutic agent in cancer research. Its ability to inhibit certain enzymes has led to investigations into its potential use in treating cancer and other diseases, although further studies are required to fully understand its implications and safety.
Used in Environmental Regulation:
Due to the toxicity and potential environmental impact of 2,3-Dichloroacetoacetanilide, it is used as a subject of strict regulatory measures. These regulations aim to control its use and handling to minimize any adverse effects on the environment and human health.
Check Digit Verification of cas no
The CAS Registry Mumber 63896-87-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,8,9 and 6 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 63896-87:
(7*6)+(6*3)+(5*8)+(4*9)+(3*6)+(2*8)+(1*7)=177
177 % 10 = 7
So 63896-87-7 is a valid CAS Registry Number.
InChI:InChI=1/C10H9Cl2NO2/c1-6(14)5-9(15)13-8-4-2-3-7(11)10(8)12/h2-4H,5H2,1H3,(H,13,15)
63896-87-7Relevant articles and documents
Targeting dormant tuberculosis bacilli: Results for molecules with a novel pyrimidone scaffold
Joshi, Rohit R.,Barchha, Avinash,Khedkar, Vijay M.,Pissurlenkar, Raghuvir R. S.,Sarkar, Sampa,Sarkar, Dhiman,Joshi, Rohini R.,Joshi, Ramesh A.,Shah, Anamik K.,Coutinho, Evans C.
, p. 201 - 207 (2015/01/30)
Our inability to completely control TB has been due in part to the presence of dormant mycobacteria. This also renders drug regimens ineffective and is the prime cause of the appearance of drug-resistant strains. In continuation of our efforts to develop novel antitubercular agents that especially target dormant mycobacteria, a set of 55 new compounds belonging to the pyrimidone class were designed on the basis of CoMFA and CoMSIA studies, and these were synthesized and subsequently tested against both the dormant and virulent BCG strain of M. tuberculosis. Some novel compounds have been identified which selectively inhibit the dormant tuberculosis bacilli with significantly low IC50 values. This study reports the second molecule after TMC-207, having the ability to inhibit tuberculosis bacilli exclusively in its dormant phase. The synthesis was accomplished by a modified multicomponent Biginelli reaction. A classification model was generated using the binary QSAR approach - recursive partitioning (RP) to identify structural characteristics related to the activity. Physicochemical, structural, topological, connectivity indices, and E-state key descriptors were used for generation of the decision tree. The decision tree could provide insights into structure-activity relationships that will guide the design of more potent inhibitors. This paper reports the second molecule after TMC-207, with the ability to inhibit tuberculosis bacilli in its dormant phase. The paper reports molecules with a novel Pyrimidone Scaffold, the synthesis of which was accomplished with a modified multi-component Biginelli reaction. A classification model was generated using recursive partitioning (RP) technique to identify structural characteristics of the molecules with their varying activities.
